Clinical Trial: Pravastatin as a Prophylactic to Reduce Endothelial Injury in Pediatric Patients With Elevated Body Mass Index
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Hematopoietic Stem Cell Transplant (HSCT)
Study Type: INTERVENTIONAL
Official Title: Pilot Trial of Pravastatin as a Novel Prophylactic Medicine to Reduce Endothelial Injury in Pediatric Patients With Elevated Body Mass Index
Brief Summary:
Chemotherapy and radiation used in patients undergoing bone marrow transplant (BMT) disrupts the endothelial lining (a thin layer of cells inside the blood vessels) which is found all throughout the body including the kidney, heart, lungs, and intestines.Disruption of this endothelial lining can lead to complications such as graft-vs-host disease (GVHD), thrombotic microangiopathy (TMA) and veno-occlusive disease (VOD).The purpose of this research study is to help investigators see if pravastatin is safe and well…
Read more